Can-C™ eye-drops are the original™ brand- developed by Innovative Vision Products (IVP). This group were the first to research, publish and prove how eye-drops can reduce and even eradicate cataract. Accordingly there are active US and EU patents (and others pending) on this unique and special product.
Unique formula:
Can-C™ eye-drops are the formula from the original published human trials. They contain a purified and racemized form of n-acetylcarnosine (made in Japan); this natural dipeptide has potent anti-glycating and anti-oxidant properties that prevents lipid peroxidation. Note that the formula is important- it's not all about the n-acetylcarnosine; the specific carrier agents and their purity are also important. If you look at the Can-C™ formula you will see differences to the copycats,
(remember it is only Can-C™ that is patented in recognition of the original work). If you want the best possible results in the fastest possible time, then choose Can-CT"' to deliver them according to the clinical trials.
Clinical trial:
Patients placed two-drops of Can-C™ into their eyes twice daily for a 6-month period, the outcome was:
-90% saw an improvement in their visual acuity.
-88.9% of patients showed improvement in the clarity of their lens.
There have been numerous reports of cataract shrinkage and even disappearance with documented evidence that Can-C™ eye-drops remain effective (and safe) more than 24-months later. The most commonly expressed initial reports are that glare is significantly improved, (for example night driving is much safer) and color perception is enhanced.
Improving eye-sight:
More evidence is mounting that Can-C™ is efficacious for many conditions including:
- Cataracts (particularly the senile version)
- Glaucoma
- Presbyopia
- Corneal disorders
- Eye strain
- Ocular inflammation
- Blurred vision
- Vitreous opacities and lesions
- Diabetes mellitus complications
- Contact lens users
- Dry eye syndrome
Of special interest may be to persons who wear contact lenses. This is because Can-C™ inhibits the accumulation of lactic acid and therefore contacts can be worn for longer periods without pain. We have also received reports that Can-C™ not only aids dry-eye syndrome with its lubricants, but that Can-C™ helps to unclog proteins from the lacrimal ducts, thus releasing more natural tears onto the eye.
In a similar way, it is also believed that the unclogging of proteins in the eye's drain, (the Schlemm valve), helps to reduce intraocular pressure and thus aids glaucoma.
